Hospital
Holy Redeemer Health System
Holy Redeemer Health System was paid $9.90M by Medicaid between Aug 2018 and Dec 2024, across 148 billing codes. Its largest line is 99283, emergency room visit (moderate) — 40% of everything it billed.
33Billing provider infoHOLY REDEEMER HEALTH SYSTEM
MEADOWBROOK, PA 19046
MEADOWBROOK, PA 19046
33aNPI1750371522assigned 10/24/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.90M
24GClaims145,672
24DCodes billed148
24AFirst – last monthAug 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#33 of 154
Median peer was paid$2.82M
This provider vs. median3.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 87 | $47.54 | |
| 2019 | 911 | $126K | |
| 2020 | 27,558 | $1.26M | |
| 2021 | 53,159 | $2.85M | |
| 2022 | 19,637 | $1.74M | |
| 2023 | 21,109 | $1.93M | |
| 2024incomplete | 23,211 | $1.99M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 40% | 18,142 | 17,420 | $4.00M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 22% | 10,751 | 10,243 | $2.13M |
| G0378 | Hospital observation service, per hour | 13% | 1,142 | 1,063 | $1.27M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.8% | 2,810 | 2,708 | $274K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.3% | 4,164 | 3,825 | $227K |
| 97799 | 2.0% | 1,847 | 578 | $200K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.9% | 2,889 | 2,829 | $187K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.6% | 1,678 | 806 | $155K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.1% | 2,470 | 1,518 | $109K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 3,247 | 1,101 | $86K |
| 59025 | Fetal non-stress test | <1% | 2,129 | 1,000 | $80K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 700 | 674 | $79K |
136 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 666 | $73K |
| 76801 | <1% | 1,309 | $66K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,163 | $58K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 989 | $54K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 885 | $51K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 964 | $46K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,211 | $44K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 442 | $43K |
| 80053 | Comprehensive metabolic panel | <1% | 7,497 | $41K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 680 | $38K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,572 | $34K |
| 76830 | Ultrasound, transvaginal | <1% | 689 | $34K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 742 | $33K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,242 | $29K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 719 | $28K |
| 76641 | <1% | 404 | $25K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,163 | $25K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 613 | $24K |
| 99285 | Emergency room visit (most serious) | <1% | 301 | $23K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 212 | $19K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 261 | $16K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,856 | $15K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 669 | $15K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,378 | $15K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 106 | $15K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,047 | $15K |
| 76818 | <1% | 125 | $15K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 295 | $14K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 793 | $13K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 591 | $13K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 104 | $11K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,940 | $11K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 439 | $11K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,158 | $8K |
| 84484 | <1% | 2,028 | $8K | |
| 76813 | <1% | 117 | $8K | |
| 83880 | <1% | 541 | $8K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 376 | $7K |
| 77066 | Tomosynthesis, mammo | <1% | 63 | $7K |
| 93971 | <1% | 97 | $6K | |
| 84702 | <1% | 726 | $6K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 132 | $5K |
| 81001 | <1% | 3,310 | $4K | |
| 87631 | <1% | 100 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 193 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,138 | $3K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 25 | $3K |
| 83690 | <1% | 1,438 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 130 | $3K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 863 | $3K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 106 | $3K |
| 85730 | <1% | 1,071 | $2K | |
| 93970 | <1% | 29 | $2K | |
| 86850 | <1% | 799 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 125 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 154 | $2K |
| 85379 | <1% | 341 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 124 | $2K |
| 86900 | <1% | 985 | $2K | |
| 73610 | <1% | 101 | $2K | |
| 85610 | <1% | 1,133 | $1K | |
| 83735 | <1% | 549 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 186 | $1K |
| 86901 | <1% | 937 | $1K | |
| 72100 | <1% | 56 | $1K | |
| 87040 | <1% | 178 | $1K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 12 | $1K |
| 73630 | <1% | 124 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 150 | $1K |
| J2790 | Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) | <1% | 94 | $1K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 179 | $1K |
| 84145 | <1% | 153 | $952.59 | |
| 81003 | <1% | 953 | $946.03 | |
| 93017 | <1% | 27 | $879.94 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 122 | $780.54 |
| 77062 | <1% | 27 | $766.17 | |
| 83615 | <1% | 293 | $666.99 | |
| 73564 | <1% | 41 | $655.80 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 12 | $615.71 |
| 87081 | <1% | 572 | $605.80 | |
| 87077 | <1% | 203 | $578.92 | |
| 87186 | <1% | 156 | $519.99 | |
| 83605 | <1% | 196 | $488.80 | |
| 86140 | <1% | 339 | $485.55 | |
| 73030 | <1% | 45 | $458.31 | |
| 87430 | <1% | 132 | $402.57 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,355 | $361.94 |
| 97168 | <1% | 15 | $310.26 | |
| 82728 | <1% | 78 | $301.12 | |
| 82247 | <1% | 87 | $259.98 | |
| 74018 | <1% | 17 | $244.06 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,060 | $214.57 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 13 | $206.88 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,742 | $198.92 |
| 97161 | <1% | 25 | $175.54 | |
| 82248 | <1% | 52 | $157.36 | |
| J3490 | Unclassified drugs | <1% | 825 | $154.95 |
| 82550 | <1% | 65 | $150.25 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,272 | $118.04 |
| 73110 | <1% | 13 | $111.55 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 849 | $104.72 |
| 73140 | <1% | 15 | $95.84 | |
| 87070 | <1% | 56 | $95.22 | |
| 87210 | <1% | 25 | $89.01 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,598 | $67.16 |
| 87147 | <1% | 40 | $60.90 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 719 | $58.45 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 71 | $50.96 |
| 85378 | <1% | 29 | $49.30 | |
| 85027 | <1% | 28 | $44.21 | |
| 84156 | <1% | 57 | $41.82 | |
| 84550 | <1% | 57 | $41.19 | |
| 87641 | <1% | 28 | $39.23 | |
| 87640 | <1% | 26 | $39.23 | |
| 82570 | <1% | 39 | $38.61 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 511 | $36.02 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 777 | $19.61 |
| A6257 | Transparent film, sterile, 16 sq. in. or less, each dressing | <1% | 19 | $11.10 |
| 84703 | <1% | 249 | $10.26 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 731 | $8.82 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 28 | $8.53 |
| J2704 | Injection, propofol, 10 mg | <1% | 613 | $6.84 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 25 | $6.22 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 14 | $5.54 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 696 | $4.97 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 36 | $0.94 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 90 | $0.78 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 51 | $0.06 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 15 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 78 | $0.00 |
| 82948 | 0% | 51 | $0.00 | |
| 00000 | 0% | 71 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 40 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 82 | $0.00 |
| 96376 | 0% | 32 | $0.00 | |
| 94762 | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKEEN, MICHAEL (CFO)
| Provider | Location | Paid |
|---|---|---|
| Grand View Urgent Care, LLC. | Lansdale, PA | $683K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.